Flavonoids as Antimicrobial Agents: A Comprehensive Review of Mechanisms and Therapeutic Potential.

IF 2.2 4区 医学 Q4 BIOCHEMISTRY & MOLECULAR BIOLOGY
Vishal Sharma, Diksha Sharma, Mamta Saini, Akash Jain, Jasmine Chaudhary, Navgeet Kaur, Samir Sahoo, Sachin Kumar Singh, Kavita Goyal, A Rekha, Haider Ali, Saurabh Gupta, Md Sadique Hussain, Gaurav Gupta
{"title":"Flavonoids as Antimicrobial Agents: A Comprehensive Review of Mechanisms and Therapeutic Potential.","authors":"Vishal Sharma, Diksha Sharma, Mamta Saini, Akash Jain, Jasmine Chaudhary, Navgeet Kaur, Samir Sahoo, Sachin Kumar Singh, Kavita Goyal, A Rekha, Haider Ali, Saurabh Gupta, Md Sadique Hussain, Gaurav Gupta","doi":"10.2174/0113892010384002250628163849","DOIUrl":null,"url":null,"abstract":"<p><p>Flavonoids, plant-derived polyphenolic compounds, have garnered significant attention for their broad-spectrum antimicrobial potential, encompassing antibacterial, antifungal, and antiviral activities. These bioactive molecules exert their effects through multiple mechanisms, including disruption of microbial cell membranes, inhibition of nucleic acid synthesis, suppression of biofilm formation, and interference with key bacterial enzymes. Notable flavonoids such as quercetin, apigenin, and kaempferol exhibit potent activity against bacterial pathogens like Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa, as well as fungal pathogens such as Aspergillus fumigatus and Candida albicans. Furthermore, flavonoids can potentiate the efficacy of conventional antibiotics by inhibiting bacterial efflux pumps, a critical mechanism contributing to antibiotic resistance. Recent advancements in structure-activity relationship (SAR) studies have underscored the influence of structural modifications- such as prenylation, hydroxylation, and methoxylation-on the antimicrobial potency of flavonoids. By highlighting these insights, this review provides a unique perspective on flavonoid-based antimicrobial strategies, particularly their synergistic potential with existing antibiotics. These findings position flavonoids as promising candidates for novel antimicrobial therapies, particularly in the face of increasing antibiotic-resistant pathogens. However, further research is needed to elucidate their precise mechanisms and optimize their therapeutic applications.</p>","PeriodicalId":10881,"journal":{"name":"Current pharmaceutical biotechnology","volume":" ","pages":""},"PeriodicalIF":2.2000,"publicationDate":"2025-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current pharmaceutical biotechnology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2174/0113892010384002250628163849","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Flavonoids, plant-derived polyphenolic compounds, have garnered significant attention for their broad-spectrum antimicrobial potential, encompassing antibacterial, antifungal, and antiviral activities. These bioactive molecules exert their effects through multiple mechanisms, including disruption of microbial cell membranes, inhibition of nucleic acid synthesis, suppression of biofilm formation, and interference with key bacterial enzymes. Notable flavonoids such as quercetin, apigenin, and kaempferol exhibit potent activity against bacterial pathogens like Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa, as well as fungal pathogens such as Aspergillus fumigatus and Candida albicans. Furthermore, flavonoids can potentiate the efficacy of conventional antibiotics by inhibiting bacterial efflux pumps, a critical mechanism contributing to antibiotic resistance. Recent advancements in structure-activity relationship (SAR) studies have underscored the influence of structural modifications- such as prenylation, hydroxylation, and methoxylation-on the antimicrobial potency of flavonoids. By highlighting these insights, this review provides a unique perspective on flavonoid-based antimicrobial strategies, particularly their synergistic potential with existing antibiotics. These findings position flavonoids as promising candidates for novel antimicrobial therapies, particularly in the face of increasing antibiotic-resistant pathogens. However, further research is needed to elucidate their precise mechanisms and optimize their therapeutic applications.

类黄酮作为抗菌药物:机制和治疗潜力综述。
黄酮类化合物是植物衍生的多酚类化合物,因其广谱抗菌潜力而受到广泛关注,包括抗菌、抗真菌和抗病毒活性。这些生物活性分子通过多种机制发挥作用,包括破坏微生物细胞膜、抑制核酸合成、抑制生物膜形成、干扰细菌关键酶等。值得注意的黄酮类化合物,如槲皮素、芹菜素和山奈酚,对细菌病原体如大肠杆菌、金黄色葡萄球菌和铜绿假单胞菌,以及真菌病原体如烟曲霉和白色念珠菌表现出强大的活性。此外,黄酮类化合物可以通过抑制细菌外排泵来增强常规抗生素的功效,这是导致抗生素耐药性的关键机制。结构-活性关系(SAR)研究的最新进展强调了结构修饰-如戊烯酰化,羟基化和甲氧基化-对黄酮类化合物抗菌能力的影响。通过强调这些见解,本综述提供了基于黄酮类化合物的抗菌策略的独特视角,特别是它们与现有抗生素的协同潜力。这些发现使黄酮类化合物成为新型抗菌疗法的有希望的候选者,特别是在面对越来越多的抗生素耐药病原体时。然而,需要进一步的研究来阐明它们的确切机制并优化它们的治疗应用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Current pharmaceutical biotechnology
Current pharmaceutical biotechnology 医学-生化与分子生物学
CiteScore
5.60
自引率
3.60%
发文量
203
审稿时长
6 months
期刊介绍: Current Pharmaceutical Biotechnology aims to cover all the latest and outstanding developments in Pharmaceutical Biotechnology. Each issue of the journal includes timely in-depth reviews, original research articles and letters written by leaders in the field, covering a range of current topics in scientific areas of Pharmaceutical Biotechnology. Invited and unsolicited review articles are welcome. The journal encourages contributions describing research at the interface of drug discovery and pharmacological applications, involving in vitro investigations and pre-clinical or clinical studies. Scientific areas within the scope of the journal include pharmaceutical chemistry, biochemistry and genetics, molecular and cellular biology, and polymer and materials sciences as they relate to pharmaceutical science and biotechnology. In addition, the journal also considers comprehensive studies and research advances pertaining food chemistry with pharmaceutical implication. Areas of interest include: DNA/protein engineering and processing Synthetic biotechnology Omics (genomics, proteomics, metabolomics and systems biology) Therapeutic biotechnology (gene therapy, peptide inhibitors, enzymes) Drug delivery and targeting Nanobiotechnology Molecular pharmaceutics and molecular pharmacology Analytical biotechnology (biosensing, advanced technology for detection of bioanalytes) Pharmacokinetics and pharmacodynamics Applied Microbiology Bioinformatics (computational biopharmaceutics and modeling) Environmental biotechnology Regenerative medicine (stem cells, tissue engineering and biomaterials) Translational immunology (cell therapies, antibody engineering, xenotransplantation) Industrial bioprocesses for drug production and development Biosafety Biotech ethics Special Issues devoted to crucial topics, providing the latest comprehensive information on cutting-edge areas of research and technological advances, are welcome. Current Pharmaceutical Biotechnology is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the latest and most important developments.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信